NKGen Biotech, Inc. Common Stock$0.14 %
Analyst Rating: Hold
Stock Details
CEO
Paul Y. Song
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
63
Address
1790 Hughes Landing Boulevard, The Woodlands, TX, 77380
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for NKGen Biotech, Inc. Common Stock $0.14
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results